Italfarmaco Nordics
– an overview
More than 85 years ago, ITALFARMACO Group (ITF) was founded, driven by the passion to develop medicines in a wide range of disease areas. The company is one of the leading global Italian companies and operates in both the pharmaceutical and fine chemical industries.
Italfarmaco Nordics was established in 2024 and specializes in the area of Rare diagnoses. Our office is located in Stockholm, and we work in all Nordic countries. In collaboration with global expertise within ITALFARMACO Group, we look forward to contributing with valuable development and new treatment options.
Unusual is usual for us
Our goal is to improve the health and quality of life of those living with rare diagnoses. In our research and development, we start from the needs of patients to create innovative therapies and contribute with long-term results. Initially, we focus on neuromuscular diseases and especially Duchenne muscular dystrophy (DMD).
News & Highlights
Lorem ipsum dolor sit amet, consectetur adipiscing elit